430 studies found for:    DIABETIC MACULAR EDEMA
Show Display Options
Rank Status Study
1 Recruiting OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
Conditions: Diabetes;   Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Device: OCT imaging
2 Completed Glycemic Control and Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention: Other: Respond to therapy for diabetic macular edema
3 Completed A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Intervention: Drug: Teprotumumab
4 Completed Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
Conditions: Diabetic Macular Edema;   Macular Edema, Cystoid;   Vision Disorders;   Clinically Significant Macular Edema
Intervention: Drug: long acting intravitreal dexamethasone implant
5 Completed Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
Condition: Diabetic Macular Oedema
Intervention: Drug: Intravitreal injection of pegaptanib sodium
6 Completed
Has Results
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: Triamcinolone Acetonide + laser;   Drug: Ranibizumab + laser;   Drug: Sham injection + laser;   Drug: Ranibizumab + deferred laser
7 Completed Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA)
Condition: Diabetic Macular Edema
Interventions: Procedure: Laser photocoagulation;   Drug: Intravitreal triamcinolone;   Drug: Intravitreal bevacizumab
8 Unknown  Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)
Condition: Diabetic Macular Edema
Intervention: Drug: Ranibizumab
9 Recruiting Sub-threshold Photocoagulation of Diabetic Macular Oedema
Condition: Diabetic Macular Oedema
Interventions: Device: PASCAL Laser, Green Laser 0.75;   Device: PASCAL Laser, Green Laser 1;   Device: PASCAL Laser, 70% Yellow Laser 0.75;   Device: PASCAL Laser, 70% Yellow Laser 1;   Device: PASCAL Laser, 40% Yellow Laser 0.75;   Device: PASCAL Laser, 40% Yellow Laser 1
10 Unknown  Triple Therapy for Diffuse Diabetic Macular Edema
Condition: Diffuse Diabetic Macular Edema
Intervention: Procedure: Triple therapy for diffuse diabetic macular edema
11 Completed Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Bevacizumab;   Drug: Triamcinolone acetonide
12 Not yet recruiting Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: bevacizumab;   Device: PASCAL Endpoint Management (EpM) laser treatment
13 Recruiting 577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Device: 577-MPL;   Device: 532-SLP
14 Completed Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
Conditions: Retinal Vein Occlusion;   Diabetic Macular Edema
Intervention: Drug: KPI-121
15 Completed Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema
Condition: Clinically Significant Diabetic Macular Edema
Intervention: Drug: ranibizumab
16 Recruiting Identifying Patients With Unrecognized Treatable Diabetic Macular Edema
Condition: Diabetic Macular Edema
Intervention:
17 Recruiting Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
Conditions: Diabetes;   Diabetic Macular Oedema;   Diabetic Macular Edema;   Diabetic Retinopathy
Interventions: Drug: Avastin (Bevacizumab);   Drug: Ozurdex (dexamethasone)
18 Completed
Has Results
Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
Condition: Diabetic Macular Edema
Interventions: Drug: Bevacizumab (Avastin);   Drug: Triamcinolone;   Drug: Sham;   Procedure: Lucentis
19 Completed Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
Condition: Retinal Diseases
Interventions: Drug: Ranibizumab;   Drug: Aflibercept;   Drug: Ranibizumab and Aflibercept;   Drug: Aflibercept and ranibizumab
20 Not yet recruiting Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
Condition: Diabetic Macular Oedema
Intervention: Drug: dexamethasone intravitreal implant

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years